FDA’s Advice for Patients – Cialis, Viagra, Levitra
The FDA advises patients to stop taking Cialis, Viagra and Levitra and call a doctor or health care provider right away if they experience sudden or decreased vision loss in one or both eyes.
“Further, patients taking or considering taking Cialis, Viagra and Levitra should inform their healthcare professionals if they have ever had severe loss of vision, which might reflect a prior episode of NAION. Such patients are at an increased risk of developing NAION again,” says the FDA.
“At this time, it is not possible to determine whether these oral medicines for erectile dysfunction were the cause of the loss of eyesight or whether the problem is related to other factors such as high blood pressure or diabetes, or to a combination of these problems,” says the FDA.
The new labeling information is available along with additional information for health care providers and consumers online.
Related posts:
- FDA’s Statement
- Schering-Plough’s Comments
- Viagra, Cialis, Levitra Information Sheet Warns o f Sudden Hearing Loss
- Viagra and Blindness
- Label Change for Viagra, Cialis, Levitra
Comments
Leave a Reply
-
-
Recently Written
- Viagra and other fun with the health-care bill
- Cialis shown to help with muscle dystrophy
- Viagra aids in conceiving
- Virginia is for Viagra
- SIX MILLION MEN BUY VIAGRA ONLINE
- Viagra as a primary method of treatment of erectile dysfunction
- Generic Viagra will enable to get erection with Longer Effectiveness
- The Popularity Of Viagra Brings About A Cultural Change In Men
- Cialis Being Used To Treat Tumours
- Fake Viagra factory raided in Israel
-
Categories
